6 results for "Bruno Raynard"
Showing 1–6 · 0.41 seconds · RSS
-
Journal Article
Nutrition, Ethics and Cancer, “To name things wrongly is to add to the misfortune of the world”
Summary: Medical nutrition therapy is a full-fledged treatment such as antibiotics, antidiabetics or mechanical ventilation. Like any medical procedure, evidence-based medical nutrition therapy (from its indication and introduction, to the eventual interruption thereof) goes along with ethical…
-
Journal Article
Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia
Abstract Background A common method for diagnosing sarcopenia involves estimating the muscle mass by computed tomography (CT) via measurements of the cross‐sectional muscle area (CSMA) of all muscles at the third lumbar vertebra (L3) level. Recently, single‐muscle measurements of the psoas major…
-
Journal Article
Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?
Background: Sarcopenia has emerged as an important parameter to predict outcomes and treatment toxicity. However, limited data are available to assess sarcopenia prevalence in metastatic breast cancer and to evaluate its management. Methods: The SCAN study was a cross-sectional multicenter French…
-
Journal Article
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma
Abstract Background Cabozantinib, a standard of care metastatic renal cell carcinoma (mRCC), may be associated with weight and muscle loss. These effects of new generation VEGFR tyrosine kinase inhibitor on muscle mass loss are poorly described. Methods All cabozantinib‐treated mRCC patients from…
-
Journal Article
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening
Induction chemotherapy (7 + 3 regimen) remains the gold standard for patients with acute myeloid leukemia (AML) but is responsible for gut damage leading to several complications such as bloodstream infection (BSI). We aimed to investigate the impact of induction chemotherapy on the intestinal…
-
Journal Article
A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design
Abstract Background Elevated body mass index (BMI) represents a risk factor for cancer-related fatigue (CRF). Weight loss interventions are feasible and safe in cancer survivors, leading to improved cardio-metabolic and quality of life (QOL) outcomes and modulating inflammatory biomarkers…